David E. Lazar - 22 Dec 2025 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role: Co-Chief Executive Officer
Signature: /s/ David E. Lazar
Issuer symbol: INDP
Transactions as of: 22 Dec 2025
Net transactions value: $0
Form type: 3
Filing time: 23 Dec 2025, 19:06:26 UTC
Previous filing: 22 Dec 2025
Next filing: 05 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lazar David E.	Co-Chief Executive Officer	44, TOWER 100, THE TOWERS WINSTON, CHURCHILL, PAITILLA, PANAMA CITY, PANAMA	/s/ David E. Lazar	23 Dec 2025	0001932843

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	INDP	Common Stock						0	22 Dec 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INDP	Series AA Convertible Preferred Stock							22 Dec 2025	Common Stock	6,000,000		Direct	F2, F3, F4
holding	INDP	Series AAA Convertible Preferred Stock							22 Dec 2025	Common Stock	105,000,000		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	No shares of Common Stock are beneficially owned.
F2	On December 22, 2025, David E. Lazar (the "Reporting Person") and Indaptus Therapeutics, Inc. (the "Company"), entered into a securities purchase agreement pursuant to which the Reporting Person acquired (i) an aggregate of 300,000 shares of the Company's Series AA Convertible Preferred Stock (the "Series AA Preferred Stock") at a price of $6.00 per share and (ii) an aggregate of 700,000 shares of the Company's Series AAA Convertible Preferred Stock (the "Series AAA Preferred Stock", and together with the Series AA Preferred Stock, the "Preferred Stock") at a price of $6.00 per share. Each share of Series AA Preferred Stock is convertible into 20 shares of the Company's Common Stock at any time, subject to certain ownership limitations. Each share of Series AAA Preferred Stock is convertible into 150 shares of the Company's Common Stock at any time, subject to certain ownership limitations.
F3	The Preferred Stock is perpetual and therefore has no expiration date.
F4	The shares of Preferred Stock are convertible at the option of the Reporting Person for no additional consideration

Remarks:

No securities are beneficially owned.